Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04364282 · ClinicalTrials.gov registry record · NA
Stay In Treatment for Pediatric Weight Management
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 1,216
- Enrollment target
NCT04364282: Completed NA study, sponsored by Wake Forest University Health Sciences.
NCT04364282 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 1,216 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (13% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04364282, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,216 participants
- Enrollment target
Study Summary
Attrition from pediatric weight management programs is unacceptably high, with dropout ranging from 27-73%. This project will utilize a model that predicts dropout from treatment, increasing its power and accuracy through a multi-site observational study. This will result in a powerful tool that will be used to decrease attrition from pediatric weight management, with the potential for widespread dissemination to improve treatment outcomes.
Primary Outcome
Completion of treatment is defined as completing 6 months of participation in weight-management program (attending the recommended number of visits, and still considered active after 6 months)
Interventions
- OTHER Control
- OTHER Care team informed
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,216 participants |
| Start Date | 2020-07-06 |
| Est. Completion | 2025-03-26 |
| Phase | NA |
What the finished NCT04364282 record still lists
NCT04364282 is an interventional study that assigns participants to a tested intervention. Its 1,216 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (13% lower).
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT04364282 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04364282 about?
NCT04364282 is a clinical study titled "Stay In Treatment for Pediatric Weight Management". Attrition from pediatric weight management programs is unacceptably high, with dropout ranging from 27-73%. This project will utilize a model that predicts dropout from treatment, increasing its power and accuracy through a multi-site observational study. This will result in a powerful tool that wil...
What is the current status of trial NCT04364282?
This trial is currently completed. It is a NA study. The enrollment target is 1,216 participants. The study started on 2020-07-06. Estimated completion is 2025-03-26.
What interventions are being tested in trial NCT04364282?
The interventions under investigation include: Control (OTHER), Care team informed (OTHER).
Who is sponsoring clinical trial NCT04364282?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04364282's enrollment target sits among peer trials
1,216 83rd of 2000 higher than 1,918 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05827016 · 1,216 participants · Phase 3
A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma
- NCT06143956 · 1,217 participants · Phase 2
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- NCT06921785 · 1,220 participants · Phase 3
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
- NCT04267848 · 1,210 participants · Phase 3
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI